Literature DB >> 33332810

PENTOSAN POLYSULFATE AND VISION: Findings from an International Survey of Exposed Individuals.

Ogul E Uner1, Megha K Shah2, Nieraj Jain3.   

Abstract

PURPOSE: To investigate patient-reported visual function among individuals taking pentosan polysulfate (PPS) for interstitial cystitis.
METHODS: A 27-item online survey was distributed to an international mailing list of individuals with interstitial cystitis in November 2018. Demographic characteristics, PPS exposure history, subjective visual function, and previous macular diagnoses were queried. The impact of PPS use, grouped by tertile of cumulative exposure, on visual function and macular diagnoses was assessed with multivariate logistic regression.
RESULTS: The survey was completed by 912 respondents. Eight hundred and sixty-one (96.4%) were women, and the median age was 55 [interquartile range (IQR), 45-64 years]. Among PPS users, the median exposure was 547.5 g (IQR, 219-1,314 g). Respondents in the highest PPS exposure tertile were more likely to report difficulty with reading small print [adjusted odds ratio 2.29, 95% confidence interval (CI) 1.15-4.57] and to have a diagnosis of macular degeneration and/or pigmentary maculopathy (adjusted odds ratio 2.41, 95% CI 1.44-4.03) than unexposed respondents.
CONCLUSION: In this large sample of individuals with interstitial cystitis, those in the highest PPS exposure category were more likely to have difficulties reading small print and to report a previous diagnosis of macular disease. Further study of objective measures of visual function in PPS users is warranted.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33332810      PMCID: PMC8200367          DOI: 10.1097/IAE.0000000000003078

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   3.975


  16 in total

1.  [Thrombocid: a new synthetic anticoagulant].

Authors:  C FRILEUX
Journal:  Presse Med       Date:  1951-02-07       Impact factor: 1.228

2.  Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.

Authors:  Sandra H Berry; Marc N Elliott; Marika Suttorp; Laura M Bogart; Michael A Stoto; Paul Eggers; Leroy Nyberg; J Quentin Clemens
Journal:  J Urol       Date:  2011-06-16       Impact factor: 7.450

3.  Prevalence of age-related macular degeneration in the US population.

Authors:  Ronald Klein; Chiu-Fang Chou; Barbara E K Klein; Xinzhi Zhang; Stacy M Meuer; Jinan B Saaddine
Journal:  Arch Ophthalmol       Date:  2011-01

4.  Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.

Authors:  Adam M Hanif; Rachel Shah; Jiong Yan; Jithin S Varghese; Shivani A Patel; Blaine E Cribbs; Ghazala O'Keefe; Andrew M Hendrick; Jessica G Shantha; G Baker Hubbard; Purnima S Patel; Prethy Rao; Steven Yeh; Nieraj Jain
Journal:  Ophthalmology       Date:  2019-04-18       Impact factor: 12.079

5.  Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy.

Authors:  Robin A Vora; Amar P Patel; Ronald Melles
Journal:  Ophthalmology       Date:  2020-01-17       Impact factor: 12.079

6.  Analysis of long-term Elmiron therapy for interstitial cystitis.

Authors:  P M Hanno
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

7.  A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.

Authors:  C L Parsons; G Benson; S J Childs; P Hanno; G R Sant; G Webster
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

8.  Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study.

Authors:  J Curtis Nickel; Sender Herschorn; Kristene E Whitmore; John B Forrest; Peter Hu; Andrew J Friedman; Alan S Baseman
Journal:  J Urol       Date:  2014-09-20       Impact factor: 7.450

9.  Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study.

Authors:  Adam M Hanif; Stephen T Armenti; Stanford C Taylor; Rachel A Shah; Austin D Igelman; K Thiran Jayasundera; Mark E Pennesi; Rahul N Khurana; Jenelle E Foote; Ghazala A O'Keefe; Paul Yang; G Baker Hubbard; Thomas S Hwang; Christina J Flaxel; Joshua D Stein; Jiong Yan; Nieraj Jain
Journal:  JAMA Ophthalmol       Date:  2019-11-01       Impact factor: 7.389

10.  Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018.

Authors:  MeLisa R Creamer; Teresa W Wang; Stephen Babb; Karen A Cullen; Hannah Day; Gordon Willis; Ahmed Jamal; Linda Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-15       Impact factor: 17.586

View more
  2 in total

Review 1.  Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Authors:  Chirantan Mukhopadhyay; Timothy M Boyce; Karen M Gehrs; James C Folk; Robert F Mullins; Yi Luo; Karl Kreder; Elliott H Sohn
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2022 Mar-Apr 01

2.  Pentosan Polysulfate Sodium-Associated Pigmentary Retinopathy: Risk Factors and Fundus Findings.

Authors:  Ella H Leung; Sahana Sharma; Ana Levie-Sprick; Gregory D Lee; Hyung Cho; Krishna Mukkamala
Journal:  Clin Ophthalmol       Date:  2021-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.